Filter posts

Greenwood Shines Spotlight on Insurance Industry Rip-off

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a …

Another Year, Another Misleading Insurance Company Report

Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear …

Patient Advocates Sounding the Alarm Over Fail First

The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare …

Co-Pay Accumulator Programs Are a Bad Deal for Patients

As we see time and time again, health insurance providers and pharmacy benefit managers (PBMs) …

Fact Checking Misleading Claims about Drug Costs

In a series of new blogs, AHIP once again paints drug manufacturers as the culprit …

NYTimes Reports Insurers are Struggling, Their Own Data Says Otherwise

The New York Times’ Reed Abelson yesterday reported on the plight of insurers who are …

Time for AHIP to Finally Join Us And Work Toward A Solution

I worked as an elected leader in government for 24 years. One of the enduring …

Harvard Law Advocates for Patient Access to Hepatitis C Cure

There is hope for the 3.5 million people living with Hepatitis C virus (HCV) in …

Sara Radcliffe: Legislature Shouldn't Put Hurdles in Way of Cancer Treatments

Check out California Life Sciences Association (CLSA) president and chief executive officer Sara Radcliffe’s op-ed …

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. …